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Embryonic stem cells (ESCs) represent a transient biological state, where pluripotency is
coupled with fast proliferation. ESCs display a constitutively active DNA damage response
(DDR), but its molecular determinants have remained elusive. Here we show in cultured ESCs
and mouse embryos that H2AX phosphorylation is dependent on Ataxia telangiectasia and
Rad3 related (ATR) and is associated with chromatin loading of the ssDNA-binding proteins
RPA and RAD51. Single-molecule analysis of replication intermediates reveals massive ssDNA
gap accumulation, reduced fork speed and frequent fork reversal. All these marks of repli-
cation stress do not impair the mitotic process and are rapidly lost at differentiation onset.
Delaying the G1/S transition in ESCs allows formation of 53BP1 nuclear bodies and sup-
presses ssDNA accumulation, fork slowing and reversal in the following S-phase. Genetic
inactivation of fork slowing and reversal leads to chromosomal breakage in unperturbed ESCs.
We propose that rapid cell cycle progression makes ESCs dependent on effective replication-
coupled mechanisms to protect genome integrity.
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T
he earliest stages of mammalian embryogenesis are
dedicated to the rapid division of totipotent cells in the
morulas, later organized in the inner cell mass (ICM) of
the blastocysts, from which embryonic stem cells (ESCs) are
derived. Although ESCs can be maintained for long periods in cell
culture, the equivalent cells in the ICM exist only transiently
(5–6 cell divisions), in a period preceding the onset of
differentiation1. Several reports have compared the DNA
damage response (DDR) in ESCs with that in differentiated
cells upon exogenous genotoxic insults2–5. However, little is
known about how ESCs cope with endogenous stress that may
arise during early embryogenesis. In ESCs, active proliferation
needs to be compatible with accurate and complete DNA
replication, to execute the developmental programme in a
timely manner, without compromising genome stability in the
embryo. Unexpectedly, it was previously reported that this stage
is associated with constitutive DDR activation (phosphorylation
of the histone variant H2AX, or gH2AX)6–9. However, as gH2AX
appearance is not dependent on the activity of the apical
checkpoint kinase ATM, and is not associated with the double-
strand break (DSB) marker 53BP1, gH2AX was attributed to
undeﬁned peculiarities of ESC chromatin structure. Hence, the
possible presence of DNA damage in these cells has remained
controversial and elusive.
An important feature that sets ESCs apart from mature cells is
the different organization of the cell cycle10,11. Differentiated
cells spend a relatively large proportion of their time in the gap
phases (G1 and G2) and lesser time in the S-phase. Conversely,
asynchronously growing ESCs have remarkably short gap phases
and spend most of their time in the S-phase, although the time
spent for genome duplication is not signiﬁcantly different from
that in somatic cells12. In line with their high proliferative
capacity, most positive cell cycle regulators and DNA replication
factors (for example, CDC25A, CDC6, cyclins and so on) are
extremely abundant in ESCs compared with mouse embryonic
ﬁbroblasts (MEFs)13 and their levels drastically drop down on
ESC differentiation14. This unusual cell cycle control is
orchestrated by key stem cell factors5,15 and was shown to be
essential to maintain pluripotency in ESCs16,17. Furthermore,
ESCs are reported to have a compromised G1–S checkpoint2,18.
The tumour suppressor protein retinoblastoma, which is required
for prevention of aberrant G1–S progression, thereby preventing
damaged DNA from being replicated, is active in MEFs, but
inactive in ESCs19. In principle, this could enable ESCs to enter
S-phase in the presence of unrepaired damage.
In this study, we have investigated the molecular determinants
of the constitutive DDR activation observed in ESCs. We found
several unexpected markers of genotoxic stress during ESC
replication, which explain activation of the Ataxia telangiectasia
and Rad3 related (ATR) pathway and result from cell cycle
adaptations of ESCs, speciﬁcally from the fast transition through
the G1 phase. We propose that fast proliferating ESCs lack
effective mechanisms to delay G2/M and G1/S transitions on
incomplete replication, but effectively protect genome integrity
by replication-coupled mechanisms. As hyperproliferation
and replication problems in adult stem cells have been recently
linked to cancer onset and stem cell attrition20,21, molecular
mechanisms related to those described here in early
embryogenesis may underlie key causative events in human
disease.
Results
RPA/RAD51 chromatin loading in early embryogenesis. To
shed light on the molecular determinants of gH2AX formation in
ESCs, we tested whether other markers of genotoxic stress are
also detectable in these cells. We conﬁrmed that, unless
irradiated, ESCs are devoid of 53BP1 foci (Supplementary
Fig. 1a)9, but also found that gH2AX in unperturbed ESCs is
invariably associated with extensive chromatin loading of RPA32
and RAD51, two single-stranded DNA (ssDNA)-binding proteins
involved in recombinational mechanisms at DSBs and stalled
forks22. All three markers are lost simultaneously on induction of
differentiation by removal of leukaemia inhibition factor (LIF)23,
as soon as the stem cell marker Oct4 is lost from the
differentiating cells (ESC-d) and while cells are still largely
undergoing active proliferation (Fig. 1a–c). Similar observations
were made in different ES cell lines, under different cell culture
conditions (Supplementary Fig. 1b,c) and were conﬁrmed in vivo
by staining of pre-implantation mouse embryos at the morula
and blastocyst stage (Fig. 1d; Supplementary Figs 2 and 3).
Biochemical fractionation conﬁrmed extensive chromatin loading
of RPA and RAD51 in ESCs, compared with the levels observed
in differentiating and differentiated cells (Fig. 1e). Furthermore,
ATM inhibition by KU55933 reduced infrared-induced gH2AX
in ESCs, but had no effect on endogenous gH2AX levels in these
cells (Fig. 1f; Supplementary Fig. 1d,e), as previously reported6.
Conversely, 8-h treatment with ATR inhibitors (ETP-46464
or VE-821) did not affect ESC proliferation, but markedly
reduced endogenous gH2AX (Fig. 1f; Supplementary Fig. 1f–h).
Altogether, these data strongly suggest that ESCs experience bona
ﬁde replication stress, which is rapidly suppressed on onset of
differentiation.
ssDNA and fork remodelling in ESCs until differentiation onset.
As RPA32/RAD51 staining are suggestive of ssDNA accumula-
tion, we applied an established single-molecule approach to
stabilize replication intermediates in cultured cells and visualize
them by electron microscopy24. Replication intermediates in
ESCs display a striking accumulation of ssDNA gaps, with
multiple gaps present in over 60% of the forks (Fig. 2a,b),
frequently also on parental DNA (Fig. 2a; Supplementary Fig. 4a).
As for other experimental conditions associated with template
discontinuities25,26, ssDNA gap accumulation is accompanied by
frequent replication fork reversal (Fig. 2c,d; Supplementary
Fig. 4b), a protective transaction previously described at
replication forks challenged by cancer chemotherapeutic
treatments26–28. Strikingly, both ssDNA accumulation and fork
reversal are rapidly and markedly suppressed on induction of
differentiation (Fig. 2b,d). Incomplete Oct4 loss at this early time
point of differentiation is likely to account for the residual levels
of ssDNA and reversed forks observed (Fig. 2b,d; Supplementary
Fig. 4c). These marks of replication stress in ESCs are associated
with a marked reduction in replication fork speed measured by
DNA ﬁbre spreading compared with differentiating and
differentiated counterparts (Fig. 2e). Reduced fork speed in
ESCs was also observed with shorter labelling times and on
inhibition of origin ﬁring (Supplementary Fig. 4d–f), excluding
that these data reﬂect frequent fork termination due to reduced
replicon size in these cells29.
Replication stress in ESCs does not perturb mitosis. While
addressing the molecular determinants of ssDNA accumulation
in ESCs, we tested several hypotheses, possibly associated
with peculiarities of stem cell biology, using FACS/IF-based
assessment of gH2AX on genetic or chemical perturbations
(Supplementary Figs 5 and 6). In this way, we excluded that the
DDR in ESCs speciﬁcally reﬂects oxidative stress or nucleotide
shortage (Supplementary Fig. 5a–f), previously reported to
mediate replication stress in other experimental systems30–32.
Furthermore, two different transcription inhibitors failed to
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Figure 1 | Replication stress markers are present in vitro in ESCs and in vivo in ICM cells. (a) Immunoﬂuorescence (IF) staining of an embryonic stem
cell (ESC) colony and partially differentiated ESCs (ESC-d; 3d from LIF removal) for the stem cell marker Oct4, the DNA damage marker gH2AX and
chromatin-bound ssDNA-binding proteins RPA32 and RAD51. Scale bars, 25mm. (b) FACS analysis of EdU incorporation and DNA content (DAPI) in ESC
and ESC-d. The percentage of cells in the different cell cycle phases is indicated. (c) Quantiﬁcation of double IF-stainings displayed in a) in ESC and ESC-d.
A minimum of 150 cells were scored in each double staining. (d) IF staining for gH2AX, RPA32 and RAD51 of E3.5 blastocysts. Number of embryos
analysed per staining was 12, 11 and 9, respectively. Representative images are shown (see also Supplementary Figs 2 and 3). Scale bar, 25mm. (e)
Immunoblot detection of the indicated proteins after biochemical fractionation performed on ESC, ESC-d and mouse embryonic ﬁbroblasts (MEFs).
Cytosolic kinase MEK2 and chromatin-bound H3 serve as fractionation controls. Original ﬁlms were scanned at high resolution and the intensity of
immunoblot signals was quantiﬁed with ImageJ. C, chromatin-enriched fraction; S, soluble fraction (includes cytosol and abundant nucleosoluble proteins);
W, whole-cell extract. Histograms represent chromatin/soluble (C/S) ratios for RPA32 (left) and RAD51 (right). (f) FACS-based quantiﬁcation of gH2AX
staining in ESCs on mock, ATM inhibitor (ATMi) or ATR inhibitor (ATRi) treatment. All these experiments were performed in duplicate. a.u., arbitrary units.
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reduce gH2AX levels in ESCs (Supplementary Fig. 5g–j); thus,
although replication/transcription interference may contribute
to replication stress in ESCs, it does not seem the key under-
lying mechanism of constitutive DDR activation in early
embryogenesis. We also excluded that ssDNA gap accu-
mulation results from active demethylation—a base excision
repair-associated process mediating the epigenetic repro-
gramming in ESCs33—as inactivation of key enzymatic
activities in this process also had no detectable effect on the
observed gH2AX levels (Supplementary Fig. 6a–e). Although
partial and combined contributions of the above mechanisms
cannot be formally ruled out, we next focused on other potential
ESC-speciﬁc sources of genotoxic stress. As both ssDNA
accumulation and fork reversal were recently reported on
induction of multiple replication rounds within a given
S-phase25, we hypothesized that replication stress in
unperturbed ESCs may reﬂect their peculiar cell cycle
progression10 with replication rounds in rapid succession—
spaced by short gap phases12—and the absence of a functional
G1/S checkpoint2,18. To test the hypothesis that speciﬁc cell
cycle constraints may underlie the observed marks of replication
stress, we delayed progression through G2/M- or G1/S-phase
transitions and tested whether those cells experiencing a
prolonged G1 or G2 phase would detectably suppress the
DDR (gH2AX ), while retaining stem cell properties (Oct4þ ).
G2/M arrest was achieved by a PLK1 (BI-6727) or a CDK1
inhibitor (RO-3306), while G1 delay was induced by a CDK4/6
(LY-2835219) or a CDC7 inhibitor (PHA-767491). Only a small
fraction of cycling ESCs displayed low levels of gH2AX while
quickly transitioning through G1 (Fig. 3a–c). The proportion of
gH2AX Oct4þ cells was not increased by extending the
length of the G2 phase (Fig. 3a–c). In contrast, a delay in the
G1/S transition did result in the accumulation of gH2AX
Oct4þ cells, particularly evident in the cells effectively arrested
with unreplicated DNA on CDC7 inhibition (Fig. 3a–c). These
data, combined with previous observations (Figs 1 and 2),
suggest that accumulated replication stress in ESCs is unlikely to
be addressed in mitosis, but can instead be dealt within the
following G1, if cells are allowed to spend sufﬁcient time in this
phase. We thus tested directly whether cycling ESCs display
aberrant mitotic structures that are typically associated with
unﬁnished replication in somatic cells, such as chromatin
bridges, micronuclei and ultraﬁne DNA bridges34. Surprisingly,
despite markedly lower levels of replication stress marks than in
ESCs (Figs 1 and 2), MEFs displayed higher endogenous levels
of unresolved mitotic structures, which as expected were further
induced by aphidicolin addition, an established treatment to
challenge replication completion (Fig. 3d–f). Conversely, albeit
displaying and signalling marked features of replication stress,
unperturbed ESCs showed limited numbers of mitotic defects,
which were only marginally increased on aphidicolin treatments
(Fig. 3d–f). These surprising data strongly suggest that the
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Figure 2 | ESCs display massive accumulation of ssDNA gaps, reduced fork speed and frequent fork reversal. (a,c) Electron micrographs of
representative replication forks from ESCs, with indicated parental (P) and daughter (D) duplexes. White arrows indicate ssDNA gaps; black arrow points
to the regressed arm (R) of a reversed fork. Insets: (a), a magniﬁed ssDNA gap; (c), the four-way junction at the reversed fork. Scale bar, 500bp
(¼ 217 nm), 200bp in inset. (b) Frequency of replication forks isolated from ESCs and differentiating ESCs (ESC-d) with the indicated number of ssDNA
gaps. (d) Frequency of reversed replication forks isolated from ESC and ESC-d. The number of replication intermediates analysed is indicated in
parentheses. Similar results were obtained in an independent experiment. (e) DNA ﬁbre spreading of ESC, ESC-d and MEF. CldU/IdU-containing tracts
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computed using Mann–Whitney test.
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mitotic process in ESCs is tuned to tolerate elevated levels of
replication stress, as those reported above for cultured ESCs and
mouse blastocysts.
A short G1 causes replication stress in stem and mature cells.
Differently from the G2/M-phase, prolongation of the G1 phase
by two different inhibitors signiﬁcantly reduced gH2AX signal-
ling in ESCs (Fig. 3a–c). Intriguingly, the G1 phase was recently
reported to allow the assembly of large 53BP1 foci (nuclear
bodies, NBs) in somatic cells35. These specialized chromatin
machineries in the G1 phase are clearly distinct from small DNA
damage-induced 53BP1 foci and were suggested to shield residual
DNA damage or unreplicated regions from the previous S-phase,
possibly assisting their repair before or during a new replication
round35. We thus tested whether a prolonged G1 phase on ESC
differentiation could be linked to the presence of 53BP1 NBs in
this cell cycle phase. To achieve this, we combined quantitative
image-based cytometry36—which identiﬁes G1 cells in
asynchronous cell populations by low DNA content (DAPI)
and lack of EdU incorporation (Supplementary Fig. 6f)—with
quantitative measurements of focal protein accumulation37,38.
This approach indeed revealed that, in unperturbed conditions,
ESCs in G1 are practically devoid of 53BP1 NBs. However,
shortly after induction of differentiation (ESC-d), along with
prolongation of this cell cycle stage, G1 cells accumulated 53BP1
NBs (Fig. 4a,b; Supplementary Fig. 6f). To further explore the
hypothesis that a short G1 phase underlies constitutive DDR
activation in ESCs, we performed the reciprocal experiment,
shortening the G1 phase in differentiated cells (MEFs) and
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the indicated treatments. PLK1i (BI-6727) and CDK1i (RO-3306) treatments delay progression through G2/M, while CDK4/6i (LY-2835219) and CDC7i
(PHA-767491) treatments delay S-phase entry. The top-left quadrant identiﬁes the subpopulation of stem cells (Oct4þ ) that display negative gH2AX
staining. (b) Student’s t-test of the subpopulation of Oct4þ gH2AX cells (red) identiﬁed in a, across three independent experiments. Error bars indicate
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independent experiments.
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assessing markers of replication stress and DDR activation.
Shortening of the G1 phase in differentiated mouse cells can be
achieved by inactivation of the APC/C activator FZR1 (ref. 39).
Indeed, small interfering RNA (siRNA)-mediated FZR1 depletion
in MEFs reduced the fraction of G1 cells and concomitantly
decreased the number of 53BP1 NBs per G1 nucleus (Fig. 4c–e),
thus phenocopying what we found in unperturbed ESCs with an
intrinsically short G1 phase. Importantly, in these experimental
conditions, S-phase cells displayed markedly increased gH2AX
signalling, reduced replication fork progression by DNA ﬁbre
assays and higher levels of ssDNA gaps and reversed forks
detected by our electron microscopy approach (Fig. 4e–h).
Altogether, these results strongly suggest that a prolonged G1
phase and/or the associated assembly of 53BP1 NBs are required
to avoid replication stress and to prevent the consequent
activation of the ATR-checkpoint in the following S-phase.
A prolonged G1 phase suppresses replication stress in ESCs.
Prompted by the above evidence, we tested directly
whether a transient G1 arrest in ESCs—by CDC7 inhibition
(Fig. 3a)—would be sufﬁcient to suppress the marks of replication
stress in the following S-phase. On release from this transient G1
arrest, ESCs indeed displayed reduced gH2AX staining and a
faster rate of replication fork progression (Fig. 5a,b). Strikingly,
this transient delay in the G1/S transition was also sufﬁcient to
effectively suppress ssDNA accumulation and fork reversal on
ESC replication intermediates in vivo analysed by electron
microscopy (Fig. 5c,d). Taken together, these data strongly sug-
gest that all unusual molecular hallmarks of ESC replication
reﬂect the rapid succession of multiple replication rounds.
Fork slowing and reversal protect ESCs from chromosome breaks.
We and others have recently reported some genetic dependencies
for replication fork slowing and reversal on genotoxic treatments
of somatic cells, that is, Poly (ADP-ribose) polymerase (PARP)
and the central recombinase RAD51 (refs 26,28,40). Therefore,
we set out to test the physiological relevance of replication
fork remodelling in the face of endogenous replication stress
in otherwise unperturbed ESCs. Indeed, PARP inhibition by
Olaparib in ESCs led to unrestrained fork progression (Fig. 6a)
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in both populations. gH2AX positive cells are depicted in red. Cell populations in G1 and S-phase are also depicted. (f) DNA ﬁbre analysis to assess fork
progression in mock-depleted and FZR1-depleted MEFs. The IdU replicated track length was computed using Mann–Whitney test. (g,h) EM-based
assessment of the percentage of replication intermediates containing ssDNA gaps (g) and the percentage of reversed forks (h) in genomic DNA extracted
from mock-depleted and FZR1-depleted MEFs.
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and to a marked (threefold) reduction in the frequency of
reversed forks (Fig. 6b). Importantly, these defects were asso-
ciated with detectable accumulation of small chromosomal
fragments—likely resulting from frequent replication fork
breakage (Fig. 6c)—and with defective completion of genome
duplication (Supplementary Fig. 7a). Due to the abundance and
the essential role of RAD51 in ESCs, its complete depletion by
siRNA was difﬁcult to achieve (Supplementary Fig. 7b). However,
the observed reduction in RAD51 levels was sufﬁcient to
signiﬁcantly increase fork speed and progressively impair efﬁcient
fork reversal (Fig. 6d,e), in keeping with recent evidence in
somatic cells on genotoxic treatments28. Also in this independent
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condition of defective fork slowing and reversal, we observed
signiﬁcant and progressive accumulation of chromosomal
breakage. The breaks occur while most cells are still actively
proliferating (Supplementary Fig. 7c) and thus precede cell cycle
arrest, which is expected on prolonged RAD51 depletion41. Taken
together, these data suggest that replication fork slowing and
reversal are essential in unperturbed ESCs to prevent the breakage
of replicating chromosomes, which are challenged by endogenous
replication stress.
Discussion
The process of genomic duplication is usually challenged by
under-replicated regions, which are frequently associated with
late-replicating and difﬁcult-to-replicate loci34,42. Thus, full
genome replication often requires the delay of mitotic onset;
furthermore, cells may eventually attempt segregation of partially
replicated chromosomes, completing DNA synthesis in the
following cell cycle34. Proliferating somatic cells take advantage
of a prolonged G1 phase to complete genome duplication, using
specialized mechanisms—such as the assembly of 53BP1 NBs35—
that are proposed to mediate template quality control before the
onset of a new replication round (Fig. 7). In line with this notion,
we now report that shortening the G1 phase in differentiated cells
is sufﬁcient to impair the assembly of 53BP1 NBs and to induce
the full set of unusual replication features detected in unperturbed
ESCs. Conversely, prolongation of the G1 phase is sufﬁcient to
restore 53BP1 NBs assembly and to largely suppress replication
stress marks in ESCs (Supplementary Fig. 7d). Thus, our
data bring further support to the notion that 53BP1 NBs do
represent specialized chromatin factories promoting DNA
repair before or during a new replication round35, in response
to both endogenous and exogenous sources of genotoxic stress
(Supplementary Fig. 7d). The detailed molecular mechanisms
underlying these DNA repair events will merit further
investigation.
In contrary to differentiated cells, ESCs appear highly tolerant
of endogenous and exogenous replication stress while undergoing
mitosis. We found reduced levels of unresolved mitotic structures,
despite obvious markers of endogenous replication stress being
detected in these cells, even when exogenous stress was induced
by aphidicolin treatment. It is likely that the type of DNA damage
accumulated in these cells at the end of replication—mostly
ssDNA gaps on replicated duplexes—may not interfere with
spindle elongation and chromosome segregation and may thus be
ineffective in activating cell cycle checkpoints. Whether speciﬁc
molecular features of the mitotic apparatus actively promote cell
division in ESCs even in the presence of residual stress will
need further investigation. Besides this unrestrained transition
through mitosis, a particularly short G1 phase is also somehow
instrumental in ESCs maintaining self-renewal16,17. Furthermore,
these cells lack the molecular mechanisms that delay S-phase
entry in the presence of DNA damage18. In light of these
combined observations, we propose that ESCs do not ﬁnalize a
replication round before the onset of the following S-phase
(Fig. 7). This leads to a discontinuous replication template and
forces these cells to undergo simultaneous replication and repair
synthesis. The abundance of simultaneous DNA synthesis events
in these cells, exacerbated by the increased usage of replication
origins43, may exhaust limiting factors for DNA synthesis and
further affect the replication process44, contributing to the
observed accumulation of ssDNA. In this respect, prolonging
the G1 phase may assist the following replication round not only
by providing more time for full genome duplication, but also by
modulating the level of limiting replication factors and/or the
number and distribution of licensed replication origins, thereby
preventing accumulation of replication stress. In keeping with
this, treating ESCs with Roscovitine—a CDK inhibitor known to
limit origin activity—leads to a ﬁvefold increase in the number of
stem cells losing gH2AX, mostly residing within the G1 phase
(Supplementary Fig. 7e,f).
Despite the short residence time in G1 phase and the associated
consequences in terms of replication stress, we propose that ESCs
can effectively tolerate this stress for those few cell division cycles
that they undergo in nature, by exploiting replication-coupled
control of genome stability. Unperturbed ESCs seem extremely
efﬁcient in promoting replication fork reversal, even in the
absence of exogenous damage. In line with recent data obtained
in somatic cells on genotoxic treatments26,28, we report here that
the accumulation of reversed forks in ESCs depends on the key
recombinase RAD51 and on PARP activity. Genetic inactivation
of either factor in unperturbed ESCs impairs effective fork
slowing and reversal, which rapidly results in chromosomal
breakage. These results strongly suggest that controlled fork
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Figure 7 | Model depicting differential control of genome stability in ESCs and proliferating somatic cells. Under-replicated regions and residual DNA
damage are unavoidably present at the end of each S-phase in both ESCs and somatic cells. However, owing to the brief gap phases, ESCs channel a high
number of these lesions in the following S-phase and protect genome integrity by extensive fork reversal and replication-coupled repair. Conversely,
differentiated cells have prolonged gap phases, assemble 53BP1 NBs and repair most of these lesions before S-phase entry (see also Supplementary
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progression and remodelling play a pivotal role in protecting the
integrity of replicating chromosomes in ESCs, which have
extremely short gap phases and thus rely entirely on genome
maintenance during replication (Fig. 7). Considering the
abundance of RAD51 and its essential function in early
embryogenesis41,45, it is tempting to speculate that the essential
developmental role of RAD51 and possibly other homologous
recombination factors reﬂects their extensive involvement in
replication fork remodelling, to prevent chromosomal breakage
during active proliferation in early embryogenesis. Conversely,
the well-established role of HR factors in DSB repair may become
more relevant in germ and somatic cells after programmed DSB
formation and/or exposure to environmental clastogens. In this
respect, as new molecular mechanisms modulating in vivo
replication fork remodelling and restart are being uncovered27,
it will be important to test their speciﬁc contribution to genome
integrity in early embryogenesis. Interestingly, besides the G1
shortening induced in MEFs by FZR1 depletion, also the
activation of oncogenes that accelerate the G1–S transition—
that is, CyclinE46—induces in somatic cells molecular hallmarks
of replication stress that are almost identical to those described
here in ESCs, including frequent fork reversal. Somatic cells can
tolerate CyclinE-induced replication stress for several cell cycles
before inducing chromosomal breakage47. In this respect, our
data in ESCs consolidate the emerging notion that fork reversal
represents a widely used strategy for genome maintenance, in the
face of different types of replication stress27. It is important to
note that—besides the DNA damage tolerance mechanisms
described here—genome maintenance in early embryogenesis is
further supported by elimination of damaged cells by apoptosis,
reportedly a very active process in this biological context18.
It will be crucial, albeit challenging, to extend these studies to
adult stem cells (for example, hematopoietic stem cells),
particularly in experimental conditions where they are actively
induced to proliferate by speciﬁc stimuli48. This is particularly
important in light of recent reports suggesting that replication
stress contributes to aging and attrition of hematopoietic stem
cells, upon physiological stimuli to proliferate21,49. Remarkably,
the proliferative properties of different populations of adult stem
cells have also been recently linked to the propensity of different
tissues to undergo tumorigenesis, suggesting that replication
problems in adult stem cells can be initiating events in cancer20.
In light of these important ﬁndings, the working model described
here for replication stress in early embryogenesis may prime new
mechanistic studies on different populations of adult stem cells,
especially under cancer-relevant experimental conditions. Similar
mechanisms may also be relevant in the derivation of induced
pluripotent stem cells, and may contribute to explaining the
reported signs of replication stress and genome damage, which
limit induced pluripotent stem cell derivation and raise concerns
for their therapeutic applications50–53.
Methods
Cells and cell culture. E14, Stat3 and JM8 mouse ES cell lines, derived from the
ICM of mouse blastocysts, were provided by Paolo Cinelli (Clinic for Trauma
Surgery, University of Zurich), while immortalized MEFs were provided by
F. Althaus (Institute of Pharmacology and Toxicology, University of Zurich).
E14 were cultivated in ‘ESC medium’þ LIF and differentiation was started by LIF
removal. Stat3 and JM8 were cultivated in ‘N2B27 medium’ (see composition
below) þ 2i and differentiation was started by 2i removal. ESC medium:
Dulbecco’s Modiﬁed Eagle Medium (Sigma), 15% FBS (Gibco), 1mM Sodium
Pyruvate (Sigma), 1 Non-Essential Amino Acids (Sigma), 1 Penicillin-
Streptomycin-L-Glutamine (Life Technologies), 0.1mM b-Mercaptoethanol
(Sigma). N2B27 medium: 1:1 Neurobasal Medium:Dulbecco’s Modiﬁed Eagle
Medium/F-12 (Life Technologies), 1 Penicillin-Streptomycin-L-Glutamine
(Life Technologies), 1 N2-Supplement (Life Technologies), 1 B27 Supplement
(Life Technologies), 0.05mM 2-Mercaptoethanol (Life Technologies). LIF:
1,000Uml 1 (Millipore). 2i: 1 mM PD0325901 (Stemgent), 3 mM CHIR99021
(Stemgent). ESCs were cultivated on feeder cells (MEFs inactivated with
10mgml 1 mitomycin C) for at least two passages before performing experi-
ments. ESCs were then separated from feeder cells by trypsinization and cen-
trifugation, and grown on gelatinized tissue culture dishes (0.1% Gelatin from
porcine skin, Sigma).
Mouse morula and blastocyst isolation and staining. Mice used in these
experiments were hosted at the CNIO animal facility and maintained in SPF
conditions. All procedures were approved by the Ethics Committee of the Instituto
de Salud Carlos III and the competent organism of the Comunidad Autonoma de
Madrid. 6- to 8-week-old B6/CBA or CD1 females were induced to superovulate by
intraperitoneal injection of 5 IU pregnant mare serum gonadotropin (PMSG)
followed 48 h later by 5 IU of human chorionic gonadotropin (HCG). Matings with
fertile males of the same genetic background were set up from the day of human
chorionic gonadotropin administration. Morulas were collected at day E2.5 and
blastocysts at day E3.5 of embryonic development. In all cases, embryos were
collected in M2 medium (Sigma). After removal of the zona pellucida with acid
Tyrode’s solution (Sigma), embryos were ﬁxed with 4% paraformaldehyde,
permabilized with 0.25% Triton X-100 in PBS, blocked and incubated with primary
antibodies diluted in blocking solution (0.1% BSA, 0.01% Tween 20, 2% normal
donkey serum) overnight at 4 C, washed and incubated in secondary antibodies
for 1 h at room temperature. Stained embryos were placed in a drop of blocking
solution containing 4 mgml 1 DAPI on a glass-bottom dish, covered with mineral
oil and kept at 4 C until confocal microscopy analysis in a Leica TCS SP5
microscope equipped with objective HCX PL APO CS 63 Water (NA 1.2).
Z stacks were taken with a 1–2 mm step size. Images were processed using ImageJ.
The following primary antibodies were used: gH2AX (Millipore, 05–636) 1:500;
RPA2, Cell Signalling, 2208S) 1:100; RAD51 (Santa Cruz Biotechnology, sc-8349)
1:250. Secondary antibodies: Alexa Fluor 555 Donkey anti-Mouse (Life
Technologies, A31570); Alexa Fluor 594 Donkey anti-Rat (Life Technologies,
A21209); Alexa Fluor 488 Donkey anti-Rabbit (Life Technologies, A21206) 1:500.
Epiﬂuorescence and confocal microscopy. For immunoﬂuorescence, cultured ES
cells were ﬁxed with 4% formaldehyde/PBS, permeabilized with 0.25% Triton
X-100 and stained for g-H2AX (1:500), Oct4 (1:500), RPA (1:100), Rad51 (1:250),
53BP1 (1:500) and EdU as indicated, detected by appropriate secondary antibodies
(Alexa Fluor, 1:500) or Click-IT reaction (Life Technologies), and mounted with
Vectashield (Vector Laboratories). 0.1% PBST (0.1% Tween in 1 PBS) was used
for washes after primary and secondary antibody incubations. Images were
acquired at  63 on a Leica DMRB microscope or on a Leica TCS SP5 confocal
microscope,
For quantitative image analyses (Fig. 4b,d and Supplementary Fig. 6f),
automated wide-ﬁeld microscopy was performed on a Leica DMI 6000 inverted
microscope equipped with a motorized stage, a Tri-band bandpass ﬁlter
(DAPI/FITC/TX; BP387/11/BP 494/20/BP 575/20) and a 12-bit monochrome
EMCCD camera (Leica DFC 350 FX, 1,392 1,040 pixels, 6.4 mm pixel size).
All images were acquired under non-saturating conditions with a HCX PLAN APO
 40 (NA 1.25–0.75) oil objective. Unbiased, automated image acquisition was
performed with the Leica Matrix Screening Software. All images were imported to
the Olympus ScanR Image Analysis Software Version 2.5.1, a dynamic background
correction was applied, and nuclei segmentation was performed using the
integrated EdgeDetection module. Focal accumulations of 53BP1 and gH2AX were
quantiﬁed by using the integrated SpotDetector module. Colour-coded scatter plots
of asynchronous cell populations were generated with Spotﬁre data visualization
software (TIBCO). P values (Fig. 4b,d) were calculated by Mann–Whitney test.
Transfections and treatments. For knockdown experiments, cells were trans-
fected 24–96 h before sample collection with the indicated siRNA using RNAiMax
transfection reagent (Life Technologies) according to the manufacturer’s instruc-
tions: siLUC (100–200 nM; 50-GGUACGCGGAAUACUUCGAdTdT-30), siFZR1,
siRad51, siAPE1, siTDG (100–200 nM siGENOME SMARTpool Dharmacon). The
following reagents were used to treat ES cells for the indicated time at the indicated
ﬁnal concentrations before collection: ATM inhibitor (KU55933, Kudos; 8 h,
10 mM); ATR inhibitor (ETP-46464, provided by O. Fernandez-Capetillo, CNIO,
Madrid; 8 h, 5 mM; VE-821, Selleckchem; 8 h, 10 mM); PARP inhibitor (Olaparib,
Selleckchem; 24 h, 10mM); Reducing/scavenging agent: (N-acetylcysteine, Sigma;
10 h, 10mM); Transcription inhibitors (Cordycepin, Sigma; 100min, 50 mM;
Alpha-amanitin, kindly provided by P. Janscak, 3–6 h, 20 mM); Ape1 inhibitor
(Methoxyamine hydrochloride, Sigma; 10 h, 1 mM); CDK4/6 inhibitor (LY2835219,
Selleckchem; 4 h, 1 mM); Cdc7 inhibitors (PHA-767491, Sigma; 8 h, 10 mM; XL-413,
kindly provided by C. Santocanale, 4 h, 10 mM); CDK1 inhibitor (RO-3306, Sigma;
10 h, 10mM); PLK inhibitor (BI-6727, Selleckchem; 4 h, 500 nM); Nucleosides
(EmbryoMax, Millipore; 24 h, 5 ). Roscovitine (Seliciclib, Selleckchem; 8 h,
20 mM).
Flow cytometry. For ﬂow cytometric analysis for g-H2AX/EdU/DAPI, cells were
labelled for 30min with 10mM EdU, harvested and ﬁxed for 15min with 4%
formaldehyde/PBS. Cells were washed with 1% BSA/PBS, pH 7.4, permeabilized
with 0.5% saponin/1% BSA/PBS and stained with anti-g-H2AX antibody (#05–636;
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EMD Millipore) for 2 h, followed by incubation with a suitable secondary antibody
for 30min. Incorporated EdU was labelled according to the manufacturer’s
instructions (#C-10425; Life Technologies). For ﬂow cytometric analysis for
g-H2AX/Oct4/DAPI, cells were ﬁxed and permeabilized as described above,
followed by incubation with antibodies against g-H2AX (#9718; Cell Signalling
Technology) and Oct4 (#611203, BD Transduction Laboratories) and suitable
secondary antibodies. In both assays, DNA was stained with 1 mgml 1 DAPI.
Samples were measured on a Cyan ADP ﬂow cytometer (Beckman Coulter) and
analysed with Summit software v4.3 (Beckman Coulter). For statistical analyses,
Mann–Whitney test was applied to compute if differences in signal intensities were
signiﬁcant using Prism (GraphPad Software).
Western blotting. Cells were collected and either snap frozen in liquid nitrogen or
immediately lysed using 2 Laemmli buffer. Protein amounts were normalized
using known concentrations of BSA and protein absorbance was measured using
Cary 60 Spectrophotometer technology. SDS-gels were run at 15–18mA and
proteins were either wet-blotted overnight (30V, 4 C) or for 2 h (100V, 4 C) on
Hybond ECL transfer membrane (GE Healthcare). Membranes were blocked in 2%
ECL Advance Blocking Reagent (GE Healthcare) in 0.1% TBST (1 TBS
supplemented with 0.1% Tween 20) for at least 30min and incubated with primary
antibodies overnight at 4 C or at room temperature for 4 h in blocking solution
and secondary antibodies were added for 1 h at room temperature (in blocking
solution). Membranes were washed three times with 0.1% TBST, 10’ each, after
primary and secondary antibody incubations and detected with ECL detection
reagent (GE healthcare). Differences in protein levels were normalized against the
loading control and the signal intensity was quantiﬁed using ImageJ. For complete,
uncropped blots with size markers, see Supplementary Fig. 8.
Pulse ﬁeld gel electrophoresis. ES cells were transfected or treated as indicated
and cells were harvested by trypsinization. Agarose plugs of 2.5 105 cells were
prepared in a disposable plug mold (Bio-Rad Laboratories). Plugs were then
incubated in lysis buffer (100mM EDTA, 1% (wt/vol) sodium lauroyl sarcosinate,
0.2% (wt/vol) sodium deoxycholate, and 1mgml 1 proteinase K) at 37 C for 72 h.
Plugs were then washed four times in 20mM Tris-HCl, pH 8.0 and 50mM EDTA
before loading onto an agarose gel. Electrophoresis was performed for 21 h at 14 C
in 0.9% (wt/vol) Pulse Field Certiﬁed Agarose (Bio-Rad Laboratories) containing
Tris-borate/EDTA buffer in a pulse ﬁeld gel electrophoresis (PFGE) apparatus
(CHEF DR III; Bio-Rad Laboratories), according to the following protocol (block I:
9 h, 120 included angle, 5.5 V cm 1, 30–18 s switch; block II: 6 h, 117 included
angle, 4.5 V cm 1, 18–9-s switch; block III: 6 h, 112 included angle, 4.0 V cm 1,
9–5 s switch). The gel was then stained with ethidium bromide and analysed by the
AlphaImager system (ProteinSimple). Relative DNA DSB) levels were assessed by
comparing DSB signals for each treatment to the background levels observed in
untreated conditions using ImageJ.
Antibodies. The following primary antibodies were used: g-H2AX (#05–636;
EMD Millipore), 53BP1 (ab21083; Abcam), Oct3/4 ((#611203; BD Transduction
Laboratories), RPA (NA19L; Calbiochem), Rad51 (sc-8349; Santa Cruz
Biotechnology, Inc.), GAPDH (#AB2302; Millipore), Fzr1 (ab3242; Abcam), RNA
pol II (provided by Pavel Janscak), Ape1 (NB100–116; Novus), Tdg (provided by
P. Scha¨r), hTOPO3a (IE3; a kind gift from Aventis Pharma). For chromatin
fractionation, Rad51(sc-8349; Santa Cruz Biotechnology, Inc.), RPA32 (2208S; Cell
Signaling), MEK2 (610235; BD Transduction Laboratories), Histone-H3 (ab1791;
Abcam). The secondary antibodies used were Alexa Fluor conjugates (Alexa Fluor
488, 594 and 647; Life Technologies) for ﬂow cytometry and immunoﬂuorescence
and anti-rabbit and anti-mouse ECL (GE Healthcare) for western blotting.
DNA ﬁbre analysis. Cells were sequentially pulse-labelled with 30 mM CldU and
250mM IdU for 20min (15min where indicated) each and harvested. Cells were
then lysed and DNA ﬁbres stretched onto glass slides by tilting them. The ﬁbres
were then denatured with 2.5M HCl for 1 h, washed with PBS and blocked
with 0.2% Tween 20 in 1% BSA/PBS. CldU and IdU tracks were detected with
anti-BrdU antibodies recognizing CldU (ab6326; Abcam) and IdU (347580; BD),
respectively, and appropriate secondary antibodies. Images were acquired with a
microscope (model DMRB; Leica) equipped with a camera (model DFC360 FX;
Leica). Images were taken at  63 using Leica Application Suite 3.3.0. CldU
and IdU tract lengths were measured using ImageJ. For statistical analyses,
Mann–Whitney test was applied to compute if differences in tract lengths were
signiﬁcant using Prism (GraphPad Software).
Electron microscopy analysis of DNA replication intermediates in mouse
cells. In vivo psoralen cross-linking, isolation of total genomic DNA and
enrichment of the replication intermediates and their electron microscopy
visualization were performed as described22. In brief, cells were harvested,
and genomic DNA was cross-linked by two rounds of incubation in 10 mM
4,50 ,8-trimethylpsoralen, followed by 3min of irradiation with 366 nm ultraviolet
light. Cells were lysed, and genomic DNA was isolated from the nuclei by
proteinase K digestion and phenol–chloroform extraction. Puriﬁed DNA was
digested QJ;with PvuII-HF and replication intermediates were enriched on a BND
cellulose column. Electron microscopy samples were prepared by spreading the
DNA on carbon-coated grids and visualized by platinum rotary shadowing. Images
were acquired on a transmission electron microscope (G2 Spirit; FEI Tecnai) and
analysed with ImageJ (National Institutes of Health).
Chromatin fractionation. ESCs, differentiating ESCs and MEFs were subjected to
biochemical fractionation according to a standard protocol54. The distribution of
proteins between equivalent amounts of the soluble and chromatin-enriched
fractions was analysed by immunoblot.
Analysis of mitotic defects. Cells were inoculated on poly-L-Lysine coated glass
slides (SIGMA-Aldrich) and grown for 16 h in the absence or in the presence of
0.3 mM Aphidicolin. For ‘micronuclei’ cells were additionally treated for 6 h with
5 mgml 1 Cytochalasin-B before ﬁxation. For ‘chromatin bridges’ and ‘micro-
nuclei’, cells were ﬁxed with 4% paraformaldehyde for 20min and permeabilized
with 0.5% Triton X-100 in PBS for 1 h. For ‘ultraﬁne bridges’, cells were ﬁxed using
4% paraformaldehyde, 0.5% Triton X-100 in PBS for 20min. Slides were saturated
using BSA 3%, Triton X-100 0.5% in PBS for a minimum of 2 h. Slides were then
mounted in Vectashield mounting medium containing DAPI. The number of
chromatin bridge-containing Anaphase/Telophase cells, micronuclei-containing
bi-nucleated cells or UFB-containing Anaphase/Telophase cells was scored
manually.
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